Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MPPE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARHGEF15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR1D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPRE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KNDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CAMSAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF821 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100505851 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACTG1P17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC145845 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TULP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLMN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on